ANL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 birž. 2024 @ 16:30):
Our systems believe the stock currently is overvalued by 0.39% compare to its pairs and should correct downwards.

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China...

Stats
Dzisiejszy wolumen	245
Średni wolumen	16 374
Kapitalizacja rynkowa	56.92M
EPS	$-0.650 ( Q4 \| 2023-12-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.460 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0750 (2.23%)

AADI -3.55%

ABCL -5.21%

ABCM 0.04%

ABEO 1.09%

ABIO -1.53%

ABOS -3.61%

ABSI -13.05%

ABUS -2.52%

ABVX -2.80%

ACAD 1.51%

ACER -17.95%

ACET -2.96%

ACGN 1.29%

ACHL -1.21%

ACHV 2.24%

ACIU -1.41%

ACLX -1.12%

ACRV -2.55%

ACST -1.23%

ACXP 1.05%

ADAG -1.75%

ADAP -4.86%

ADGI 0.87%

ADIL -3.05%

ADMA -1.84%

ADPT -2.40%

ADTX -3.56%

ADVM -1.57%

ADXN -7.17%

AEON 8.63%

AEZS -4.96%

AFMD -2.61%

AGEN -7.47%

AGIO -2.86%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -1.87%

AKRO -4.50%

AKTX -8.07%

AKUS 0.00%

ALBO 0.00%

ALDX -0.27%

ALEC -2.03%

ALGS -3.99%

ALKS 0.16%

ALLK -2.16%

ALLO -3.20%

ALLR -6.09%

ALNA 3.16%

ALNY -1.68%

ALPN 0.00%

ALPX 0.00%

ALRN 0.93%

ALT -3.85%

ALVR -4.44%

ALXN 0.00%

ALXO -9.07%

ALZN -5.68%

AMRN -3.24%

AMTI -3.13%

ANAB -2.27%

ANEB -4.55%

ANGN 0.00%

ANIX 0.38%

ANL 2.13%

ANNX -3.02%

ANPC -3.15%

APGE -3.74%

APGN 8.48%

APGNW 30.65%

APLM -0.80%

APLS -0.94%

APLT -3.17%

APM -1.54%

APOP 0.38%

APRE 6.80%

APTO -2.84%

APTX 3.17%

APVO -19.56%

ARAV -13.39%

ARCT -8.54%

ARDS 20.48%

ARDX -0.24%

ARGX -2.10%

ARNA 0.00%

ARPO -0.90%

ARQT -7.31%

ARTL 0.00%

ARTLW 9.80%

ARVN -3.97%

ARWR -3.12%

ASLN -6.46%

ASMB 0.39%

ASND -2.62%

ATAI -2.55%

ATHA 0.79%

ATHE -1.07%

ATHX -33.50%

ATNF 18.87%

ATOS -4.17%

ATRA -21.64%

ATXI -3.31%

ATXS -5.03%

AUPH -3.54%

AURA 0.14%

AUTL -2.01%

AVBP 0.21%

AVEO 0.00%

AVIR -1.25%

AVRO 0.70%

AVTE -92.77%

AVTX -4.13%

AVXL -2.26%

AXLA 0.00%

AXSM 2.61%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -1.09%

BCAB -2.20%

BCDA 1.17%

BCDAW -33.33%

BCEL -1.32%

BCLI -7.35%

BCRX -0.41%

BCTX 0.21%

BCTXW 0.00%

BCYC -3.81%

BDRX -0.09%

BDTX -9.08%

BEAM -3.10%

BFRA -2.91%

BGNE -1.78%

BIOR -8.71%

BIVI -4.04%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX -2.53%

BLTE -1.88%

BLU 0.03%

BLUE 1.26%

BMEA -8.33%

BMRN 2.44%

BNOX 0.00%

BNTC 2.60%

BNTX -4.64%

BOLD -5.03%

BOLT -1.28%

BPMC -0.29%

BPTH 7.73%

BPTS -13.47%

BRNS -0.55%

BRTX 18.87%

BTAI -3.28%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 1.89%

CABA -6.75%

CADL -1.78%

CALA -37.50%

CALC -0.20%

CALT 0.03%

CAPR -1.16%

CARA -27.14%

CARM -9.65%

CASI -1.45%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.31%

CCCC -4.23%

CCXI 0.00%

CDAK 0.00%

CDIO -3.85%

CDIOW 0.00%

CDMO 2.47%

CDMOP 0.04%

CDT -5.68%

CDTTW -52.91%

CDTX -4.61%

CDXC 0.00%

CDXS -2.30%

CELC -0.40%

CELU 0.16%

CELUW -9.52%

CERC -1.68%

CERE -0.01%

CERO -7.90%

CEROW -53.43%

CFRX -27.95%

CGEM -7.19%

CGEN -6.28%

CGON -4.68%

CGTX -2.28%

CHMA -6.00%

CHRS -3.85%

CINC 0.00%

CING -1.52%

CINGW -8.54%

CKPT -1.42%

CLBS -16.75%

CLDX 1.18%

CLGN 1.94%

CLLS -6.00%

CLNN -0.16%

CLNNW -41.25%

CLRB -7.43%

CLSD -1.29%

CLSN -0.68%

CLVS 0.00%

CMMB -5.02%

CMND 1.83%

CMPI 0.00%

CMPX 0.90%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.41%

CNCE 0.00%

CNSP 3.76%

CNST 0.00%

CNTA -7.17%

CNTB 4.38%

CNTX 0.00%

COCP -2.47%

COEPW -23.50%

COGT 3.03%

CORT -1.07%

COYA -3.47%

CPRX -0.27%

CRBP -9.90%

CRBU -4.47%

CRDF -3.70%

CRGX -4.61%

CRIS 3.34%

CRNX -1.07%

CRSP -3.43%

CRTX 2.63%

CRVO 0.68%

CRVS -6.86%

CSBR 1.39%

CTCX -6.98%

CTIC 0.06%

CTMX -2.54%

CTNM -0.94%

CTXR -3.52%

CUE -2.57%

CVAC -4.35%

CVKD 5.24%

CWBR -2.55%

CYAD -12.96%

CYCC -1.18%

CYCCP -1.79%

CYCN 4.56%

CYT -2.27%

CYTK -1.35%

CYTO 0.00%

DARE -4.40%

DAWN -3.49%

DBTX -0.81%

DBVT 0.56%

DFFN 10.28%

DICE 0.06%

DMAC -4.26%

DNLI -4.58%

DNTH -2.92%

DOMH 1.49%

DRMA 3.85%

DRMAW 0.00%

DRNA 0.00%

DRTS -2.63%

DRTSW -1.05%

DRUG 1.94%

DSGN 1.58%

DTIL -1.80%

DYAI -0.49%

EARS -1.77%

EDIT -2.47%

EDSA 1.51%

EFTR -3.13%

EFTRW 0.00%

EIGR 0.00%

ELAB 0.17%

ELDN -3.63%

ELEV -4.35%

ELOX -12.50%

ELTX -3.06%

ELVN -1.24%

ELYM -9.42%

ENGN -1.33%

ENGNW -7.06%

ENLV 12.76%

ENOB 1.79%

ENSC -1.00%

ENTA -4.63%

ENTO -6.80%

ENTX -1.59%

ENVB -3.95%

EPIX -7.91%

EPRX 0.38%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS -7.59%

ERNA -2.86%

ERYP 1.30%

ESLA -2.66%

ESLAW -9.25%

ETNB 0.11%

ETON -4.49%

ETTX 0.00%

EVAX -18.89%

EVGN -2.20%

EVLO 50.00%

EWTX -0.06%

EXAI -0.22%

EXEL -0.18%

EYEG 0.04%

EYEN -2.66%

EYPT -3.36%

FATE -0.69%

FBIO 0.80%

FBIOP -1.05%

FBLG -4.78%

FBRX -6.63%

FDMT 0.47%

FENC 0.44%

FGEN -4.02%

FHTX 5.90%

FIXX 0.77%

FMTX 0.00%

FNCH -7.64%

FOLD -1.23%

FREQ 4.76%

FRLN 0.15%

FRTX 1.07%

FSTX 0.00%

FTRE 1.88%

FULC -5.30%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -2.48%

GANX 4.86%

GBIO 4.59%

GBT 0.01%

GDTC 0.50%

GERN -3.29%

GHRS 1.58%

GLMD -1.05%

GLPG 0.61%

GLSI 13.64%

GLTO -2.50%

GLUE -7.31%

GLYC -8.74%

GMAB -1.68%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.01%

GNLX -1.06%

GNPX 1.87%

GNTA -0.30%

GOSS 2.59%

GOVX -8.18%

GOVXW 2.25%

GPCR 0.54%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.17%

GRTX -4.26%

GTHX -2.70%

GUTS -3.01%

GXGXW 41.67%

GYRE 3.71%

HALO -0.54%

HARP 0.09%

HCWB -4.42%

HEPA -3.68%

HGEN -84.62%

HILS 5.66%

HLVX -0.27%

HOOK -7.01%

HOTH -3.34%

HOWL 4.01%

HRMY 0.07%

HRTX -9.44%

HSTO 62.16%

HUMA -11.28%

HUMAW -2.99%

IBRX -2.10%

ICCC -2.39%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.31%

IFRX -2.88%

IGMS -3.58%

IKNA -0.69%

IKT 0.68%

IMAB -1.90%

IMCR -2.18%

IMGN 0.02%

IMGO 0.00%

IMMP -0.92%

IMMX -0.28%

IMNM -10.59%

IMNN 0.85%

IMPL -27.27%

IMRA 15.96%

IMRN 1.39%

IMRX 3.65%

IMTX 0.61%

IMTXW -2.70%

IMUX -3.38%

IMV 0.00%

IMVT 2.58%

INAB -11.84%

INBX -9.99%

INCY 0.40%

INDP 4.70%

INFI -52.38%

INKT -1.05%

INM -3.51%

INMB -2.06%

INO -1.87%

INSM 0.28%

INTS -3.42%

INVA 2.39%

INZY -2.53%

IOBT -6.20%

IONS 0.25%

IOVA -1.78%

IPA -0.72%

IPHA -8.94%

IPSC -0.80%

IRON -4.04%

ISEE 0.38%

ITOS -4.61%

ITRM -0.87%

IVA -9.93%

IVVD -3.80%

JAGX -4.94%

JANX -2.96%

JAZZ 0.61%

JNCE 0.00%

JSPR -2.28%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -1.70%

KALV -2.57%

KDNY 0.22%

KMPH -0.34%

KNSA -1.49%

KNTE -0.38%

KOD -3.21%

KPRX -12.31%

KPTI 0.98%

KRBP 3.77%

KRON -2.10%

KROS -7.03%

KRRO -14.41%

KRTX 0.03%

KRYS 0.53%

KTRA -3.44%

KTTA 0.45%

KTTAW 8.62%

KURA -3.26%

KYMR -4.73%

KYTX -15.80%

KZIA -1.93%

KZR -3.18%

LABP 0.57%

LBPH 0.70%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.44%

LENZ 1.24%

LEXX -5.69%

LEXXW -27.54%

LGND -1.39%

LGNDV 0.00%

LGVN -19.56%

LIAN 0.00%

LIFE 2.70%

LIPO 0.31%

LIXT 0.00%

LIXTW 43.80%

LJPC -0.32%

LMNL 0.12%

LOGC 1.66%

LPCN 8.33%

LPTX -2.37%

LQDA 3.40%

LRMR -7.40%

LSTA -5.52%

LTRN -9.31%

LUMO -1.31%

LVTX -5.63%

LXEO -4.49%

LXRX -3.01%

LYEL -9.16%

LYRA -7.14%

MACK 0.00%

MBIO 349.84%

MBRX 1.93%

MCRB -4.00%

MDGL 1.37%

MDNA -13.16%

MDWD 2.40%

MDXG -1.10%

MEIP 0.35%

MESO 1.58%

MGNX -4.70%

MGTA -7.74%

MGTX -1.89%

MGX -18.29%

MIRM 21.89%

MIRO 0.59%

MIST -1.42%

MITO 0.00%

MLEC -2.73%

MLECW 0.00%

MLND -5.36%

MLTX -2.34%

MLYS -2.78%

MNKD -2.60%

MNMD -1.94%

MNOV 0.75%

MNPR -3.31%

MOLN 6.09%

MOR -1.13%

MORF -1.38%

MREO 1.18%

MRKR 16.59%

MRNA -0.78%

MRNS -1.17%

MRSN -1.93%

MRTX -0.17%

MRUS -0.60%

MRVI -3.32%

MTCR -1.29%

MTEM 5.38%

MTP -18.50%

MURA 1.24%

MYMD 2.33%

NAMS -5.29%

NAMSW -14.09%

NAUT -1.17%

NBRV 0.71%

NBSE -1.56%

NBTX 4.12%

NCNA 0.66%

NERV 7.91%

NEXI 0.00%

NGM -1.28%

NGNE -1.81%

NKGN -5.93%

NKGNW 39.76%

NKTR 0.00%

NKTX -4.15%

NLSP -0.88%

NLSPW -34.00%

NMRA -2.25%

NMTR -42.97%

NOVN -24.84%

NRBO 1.82%

NRIX -0.46%

NRSN -2.24%

NRSNW 6.54%

NRXP 1.64%

NRXPW -15.76%

NRXS 0.00%

NTBL 10.50%

NTEC -12.45%

NTHI 0%

NTLA -0.32%

NTRBW -6.25%

NUVL -0.09%

NVAX -0.91%

NVCT 3.10%

NVIV -34.28%

NXTC -9.38%

NYMX -0.05%

OABI 0.24%

OABIW 11.54%

OBIO 0.25%

OBSV 0.00%

OCEA 9.26%

OCGN -3.18%

OCS -0.67%

OCUL -6.09%

OCUP -1.81%

ODT -4.27%

OKYO 0.00%

OLMA -4.29%

OMER 0.49%

OMGA -5.91%

ONCO -2.89%

ONCR -3.08%

ONCS 31.87%

ONCT 3.52%

ONCY -1.00%

ONTX -0.47%

ONVO 2.04%

OPNT 0.00%

OPT -6.50%

ORGS -1.72%

ORIC -2.67%

ORMP -0.89%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 1.14%

OVID -69.90%

OYST 0.00%

PALI -2.59%

PASG -3.79%

PBLA 9.76%

PBM 0.00%

PBYI 1.29%

PCSA 1.71%

PCVX -1.03%

PDSB -2.69%

PEPG 1.04%

PGEN 0.61%

PHAR 5.47%

PHAS 0.00%

PHAT 2.03%

PHIO -0.41%

PHIOW 36.47%

PHVS 0.13%

PHXM -5.20%

PIRS -4.33%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -4.66%

PLUR -1.17%

PMN -7.08%

PMVP -2.10%

PNT 0.16%

PPBT -6.57%

PRAX -5.56%

PRDS 0.93%

PRLD -1.28%

PROG -3.47%

PROK 5.49%

PRQR -2.85%

PRTA 0.39%

PRTC 2.51%

PRTG -10.78%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.75%

PSTX -0.37%

PTCT 1.70%

PTE -0.82%

PTGX -1.50%

PTIXW 2.50%

PULM 1.86%

PXMD -1.92%

PYPD -2.38%

PYXS -1.03%

QLGN -11.20%

QNCX 0.00%

QNRX -8.72%

QSI -4.44%

QSIAW 0.06%

QTTB 4.89%

QURE -3.68%

RAIN -1.63%

RANI 1.74%

RAPT -0.60%

RARE 1.55%

RCKT -2.52%

REGN 0.91%

RENB -1.52%

REPL -5.74%

RETA 0.02%

REUN -0.89%

REVB -3.62%

REVBU 3.46%

REVBW 33.33%

RGLS -0.83%

RGNX -2.98%

RIGL 0.47%

RLAY -4.72%

RLMD -0.33%

RLYB -4.21%

RNA 0.66%

RNAC -8.14%

RNAZ -4.18%

RNXT 12.71%

ROIV 0.05%

ROIVW 4.56%

RPHM -1.81%

RPRX -1.56%

RPTX 0.00%

RUBY 2.70%

RVLP -32.05%

RVMD -4.45%

RVMDW -16.81%

RVNC -2.13%

RVPH -1.71%

RVPHW 11.54%

RXDX 0.09%

RXRX 0.22%

RYTM -4.09%

RYZB 0.02%

RZLT 0.89%

SABS 1.23%

SABSW -20.32%

SAGE -4.67%

SANA -2.22%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 56.15%

SCPH -0.97%

SCPS 0.00%

SEEL -2.78%

SEER -1.97%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -21.01%

SGMT 1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -1.96%

SLGL 1.92%

SLN -1.61%

SLNO -0.97%

SLRX 4.96%

SLS -14.17%

SMMT -7.89%

SNDX -1.54%

SNGX -2.96%

SNPX -4.42%

SONN -3.61%

SPPI -0.49%

SPRB -0.97%

SPRC -2.16%

SPRO -4.41%

SRNE 15.00%

SRPT -3.19%

SRRA 0.00%

SRRK -4.46%

SRZN -1.70%

STAB 0.00%

STOK -2.95%

STRO -7.08%

STSA 0.00%

STTK -17.77%

SURF -0.93%

SVRA -2.94%

SWTX -5.53%

SYBX -0.63%

SYRS -1.50%

TALS -0.73%

TARA -6.61%

TARS -5.37%

TBPH -0.35%

TCBP -7.21%

TCDA 0.00%

TCON 4.28%

TCRR 0.00%

TCRT 1.89%

TCRX -9.29%

TECH -1.54%

TENX -3.89%

TERN -2.62%

TFFP 1.57%

TGTX -1.63%

THRX 0.12%

TIL -0.78%

TLC 0.00%

TLSA 7.75%

TNGX 4.14%

TNXP -1.30%

TNYA -0.45%

TPST -2.50%

TRDA -1.14%

TRVI 4.18%

TRVN 5.00%

TSHA -2.13%

TSVT 2.41%

TTNP -2.01%

TVTX 2.44%

TYRA -9.47%

UBX -3.81%

UNCY -1.21%

URGN -2.34%

UTHR 2.74%

VACC 11.36%

VALN -1.25%

VAXX -0.84%

VBIV -4.71%

VBLT -8.77%

VCEL -1.19%

VCNX -3.70%

VCYT -0.19%

VERA -1.37%

VERU -1.27%

VERV -3.97%

VIGL -6.00%

VINC -6.09%

VIR -4.05%

VIRI 0.63%

VIRX -2.49%

VKTX 2.83%

VLON -13.04%

VNDA 5.77%

VOR -0.44%

VRCA -1.36%

VRDN -1.85%

VRNA 10.24%

VRPX 10.90%

VRTX -0.79%

VSTM -1.29%

VTGN -3.98%

VTVT -5.66%

VTYX -4.17%

VXRT -4.30%

VYGR -2.23%

VYNE -3.80%

VYNT 7.78%

WINT 0.97%

WVE -0.48%

XBIO -1.56%

XBIT -0.49%

XCUR -3.17%

XENE -2.34%

XERS -1.82%

XFOR -3.95%

XLO -7.04%

XLRN 0.00%

XNCR -3.91%

XOMA -3.20%

XOMAO 0.76%

XOMAP 0.31%

XRTX -3.43%

YMAB -1.76%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.13%

ZNTL -3.72%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2009-03-16	Blatz Robert G	Buy	0
2009-02-18	Blatz Robert G	Sell	242 547	Common Stock, par value $.01
2009-02-18	Considine Terry	Sell	83 079	Common Stock, par value $.01
2009-02-18	Rhodes Thomas L	Sell	92 328	Common Stock, par value $0.01
2008-12-31	Considine Terry	Sell	5 000	Common Stock, par value $.01

INSIDER POWER
0.00
Last 97 transactions
Buy: 1 786 556 \| Sell: 1 688 226

Korelacja (AI algo v.1.1b): Overvalued: 0.39% $2.04 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Adlai Nortye Ltd. Korelacja

10 Najbardziej pozytywne korelacje
OZEM	1
CALC	0.914
RFAIU	0.883
NNAVW	0.87
DECAU	0.866
ANSC	0.859
MTTR	0.849
RENE	0.847
DHAI	0.846
QTTB	0.842

10 Najbardziej negatywne korelacje
INTJ	-0.884
REGCO	-0.876
RENB	-0.874
ADNWW	-0.871
EPOW	-0.867
RMCO	-0.865
MGX	-0.863
HTZWW	-0.855
OMH	-0.854
CDIO	-0.854

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adlai Nortye Ltd. Finanse

Annual	2023
Przychody:	$5.00M
Zysk brutto:	$2.78M (55.56 %)
EPS:	$-2.42

FY	2023
Przychody:	$5.00M
Zysk brutto:	$2.78M (55.56 %)
EPS:	$-2.42

FY	2022
Przychody:	$0
Zysk brutto:	$-2.04M (0.00 %)
EPS:	$-0.600

Financial Reports:

No articles found.

Adlai Nortye Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Adlai Nortye Ltd.

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule EP4 antagonist to modulate the tumor microenvironment; and AN4005, an oral small-molecule PD-L1 inhibitor to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was incorporated in 2018 and is based in Grand Cayman, the Cayman Islands.